Skip to main content
. 2022 Nov 2;17(11):e0276929. doi: 10.1371/journal.pone.0276929

Fig 4. Longitudinal SARS-CoV-2-specific cellular immunity.

Fig 4

Cellular immunity was quantified by IFN-γ production upon stimulation with various SARS-CoV-2 peptide pools in ELISPOT assays normalized to numbers of circulating PBMCs (A) as well as CD3+ T cells (B) in immunosuppressed COVID-19 convalescents after liver transplantation (OLT, dark grey) compared to matched non-IS convalescents (non-IS; light grey) before the corona pandemic (pre) and in the first year after COVID-19 (m = months; vacc. = vaccination).